Quick Links

 Selected Publications

Bernstein, S.H., Nademanee, A. P., Vose, J.M., Tricot, G., Fay, J.W., Negrin, R.S., DiPersio, J., Rondon, G., Champlin, R., Barnett, M.J., Cornetta, K., Herzig, G.P., Vaughn, W., Geils, G., Keating, A., Messner, H., Wolff, S.N., Miller, K.B., Linker, C., Cairo, M., Hellman, S., Ashby, M., Stryker, S., and Nash, R.: A Multicenter Observational Study of Platelett Recovery and Utilization in Patients Undergoing Myeloablative Therapy and Stem Cell Transplantation. Blood 91:3509-3517, 1997.

Nademanee, A.P., Molina, A., O’Donnell, M.R., Dagis An., Snyder, D.S., Parker, P., Stein, A.S, Smith, E., Planas, I., Kashyap, A,. Spielberger, R., Fung, H., Wong, K.K., Somlo, G., Margolin, K., Chow, W., Sniecinski, I., Vora, N., Slovak, M., Blume, K.G., NIland, J.C., Forman, S.J.: High-Dose Therapy and Autologous Bone Marrow/Stem Cell Transplantation in Poor-Risk Intermediate and High-Grade Lymphoma: International Index High and High-Intermediate Risk Group. Blood 90:3844, 1997.

Molina, A., Nademanee, A.P., Arber, D., Forman, S.J., Remission of Refractory Sezary Syndrome after Matched Unrelated Donor Marrow Transplantation. Biology of Blood and Marrow Transplantation.  4:100, 1998.

Snyder, D.S., Nademanee, A.P., O’Donnell, M.R., Parker, P.M., Stein, A.S., Margolin, K., Somlo, G., Molina, A., Spielberger, R., Kashyap, A., Fung, H., Vora, N., Slovak, M.L., Dagis, A., Negrin, R.S., Amylon, M.D., Blume, K.G., Forman, S.J.: Long term follow-up of 23 patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia treated with Allogeneic Bone Marrow Transplantation in first complete remission. Leukemia 13:2053-2058, 1999.

Nademanee, A.P., Molina, A., Fung, H., Stein, A.S, Parker, P.M., Plana, I., O’Donnell, M.R., Snyder, D.S., Kashyap, A., Spielberger, R., Bhatia, R., Krishnan, A., Sniecinski, I., Vora, N., Slovak, M., Dagis, A., NIland, J.C., Forman, S.J.: High-Dose Chemo/Radiotherapy and Autologous Bone Marrow or Stem Cell Transplantation for Poor-Risk Advanced Stage Hodgkin’s Disease During First Partial or Complete Remission. Biology of Blood and Marrow Transplantation. 5:292-298, 1999.

Nademanee, A.P., Molina, A., Dagis, A., Snyder, D.S., O’Donnell, M.R., Parker, P.M., Stein, A.S., Smith, E.P., Planas, I., Kashyap, A., Spielberger, R., Fung, H.C., Krishnan, A., Bhatia, R., Wong, K.K., Somlo, G., Margolin, K., Chow, W., Sniecinski, I., Vora, N., Slovak, M., Niland, J.C., Forman, S.J.: Autologous Stem Cell Transplantation for Poor-Risk and Relapsed Intermediate and High-Grade Non-Hodgkin’s Lymphoma. Clinical Lymphoma, Vol. 1, 2000.

Bhatia, S., Louie, A.D., Bhatia, R., O’Donnell, M.R., Fung, H.C., Kashyap, A., Krishnan, A., Molina, A., Nademanee, A.P., Niland, J.C., Parker, P.M., Snyder, D.S., Spielberger, R., Stein,A.S., Forman, S.J.: Solid Cancers After Bone Marrow Transplantation. Journal of Clinical Oncology. 19:464-471,2001.

Fung, H.C., Nademanee, A.P., Bhatia, S., Forman, S.J.: Is there an Association between Total Body Irradiation and Secondary AML/MDS in Patients with Relapsed/Refractory Hodgkin’s Disease Treated with Autologous Stem Cell Transplantation. Journal of Clinical Oncology, Vol. 20, No. 13, Aug. 1, 2001.

Fung, H.C., Nademanee, A.P., Forman, S.J., Bone Marrow Transplant for Hodgkin’s Disease and Malignant Lymphoma, a volume in the ACS Atlas of Clinical Oncology (Edited by Michael Grossbard.) pg. 356-372, 2001.

Forman, S.J., Schmidt, G.M., Nademanee, A.P., Amylon, M.D., Chao, N.J., Fahey, J.L., Konrad, P.N., Margolin, K., Niland, J.C., O’Donnell, M.R., Parker, P.M., Smith, E.P., Snyder, D.S., Somlo, G., Stein, A.S., Blume, K.G.: Allogeneic Bone Marrow Transplantations as Therapy for Primary Induction Failure for Patients with Acute Leukemia. Classic Paper and Current Comments: Highlights of Bone Marrow Transplantation – Journal of Clinical Oncology. In press.

Fung, H.C., Nademanee, A.P.,: Approach to Hodgkin’s Disease in the New Millennium. Hematological Oncology Vol. 20, Issue 1, pg. 1-15, 2002.

Snyder, D.S., Nademanee, A.P., O’Donnell, M.R., Parker, P.M., Stein, A.S., Margolin, K., Somlo, G., Molina, A., Spielberger, R., Kashyap, A., Fung, H., Vora, N., Slovak, M.L., Niland, J., Palmer, J.M., Negrin, R.S., Amylon, M.D., Blume, K.G., Forman, S.J.: Allogeneic, Bone Marrow Transplantation for Bcr-Abl Positive Acute Lymphoblastic Leukemia in Acute Leukemia’s VII: Prognostic Factors and Treatment Strategies, Hematology and Blood Transfusion, T. Buchner, et al. Editors, Springer-Verlag: Heidelberg, Germany, pg. 414-418, 2001.

Lopez, F., Parker, P.M., Nademanee, A.P., Rodriguez, R., Al-Kadhimi, Z., Bhatia, R., Cohen, S., Falk, P., Fung, H., Kirschbaum, M., Krishnan, A., Kogut, N., Molina, A., Nakamura, R., O’Donnell, M., Popplewell, L., Pullarkat, V., Rosenthal, J., Sahebi, F., Smith, E., Snyder, D., Somlo, G., Spielberger, R., Stein, A., Sweetman, R., Zain, J., Forman, S.J.: Efficacy of Mycophenolate Mofetil in the Treatment of Chronic Graft-Versus Host Disease. Biology of Blood and Marrow Transplant, 11:307-313,2005.

Molina, A., Zain, J., Arber, D., Angelopoulou, M., O’Donnell, M., Murata-Collins, J., Forman, S.J., and Nademanee, A.P.: Durable clinical cytogenetic and molecular remissions after Allogeneic Hematopoietic Cell Transplantation for refractory Sezary syndrome and Mycosis fungoides. Journal of Clinical Oncology, 23:6163, 2005.

Nademanee, A.P., Forman, S.J., Molina, A., Fung, H., Smith, D., Dagis, A., Kwok, C., Yamauchi, D., Anderson, A., Falk, P., Krishnan, A., Kirschbaum, M., Kogut, N., Nakamura, R., O’Donnell, M.R., Parker, P.M., Popplewell, L., Pullarkat, V., Rodriguez, R., Sahebi, F., Smith, E., Snyder, D.S., Stein, A.S., Spielberger, R., Zain, J., White, C., Raubitschek, A., A phase I/II trial of high-dose Yttrium90 ibrutumomab tiuxetan in combination with high-dose etoposide and cyclophophamide followed by Autologous Stem Cell Transplant in patients with poor-risk or relapsed Non-Hodgkin’s Lymphoma (NHL). Blood, 106:2896, 2005.

Krishnan, A., Nademanee, A.P., Fung, H., Angelopoulou, M., Molina, A., Gaal, K., Dagis, A., Palmer, J., Alvarnas, J., Slovak, M., Kogut, N., Popplewell, L., Rodriguez, R., Schriber, J., Wang, S., Forman, S.J.: Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation? Biology of Blood and Marrow Transplantation, 12:641647, 2006.

This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.